Literature DB >> 25572632

Endovascular management of adjacent tandem intracranial aneurysms: utilization of stent-assisted coiling and flow diversion.

Ning Lin1, Adam M Brouillard, Jianping Xiang, Ashish Sonig, Maxim Mokin, Sabareesh K Natarajan, Chandan Krishna, L Nelson Hopkins, Kenneth V Snyder, Adnan H Siddiqui, Elad I Levy.   

Abstract

BACKGROUND: Tandem intracranial aneurysms are aneurysms located along a single intracranial vessel. Adjacent tandem aneurysms arise within the same vascular segment and their presence often suggests diffuse parent vessel anomaly. Endovascular management of these rare lesions has not been well studied. In this retrospective observational study, we describe our experience treating adjacent tandem intracranial aneurysms with endovascular embolization.
METHODS: We retrospectively reviewed records of patients with these lesions who underwent endovascular treatment between 2008 and 2013.
RESULTS: Thirteen patients (mean age 60.8 years; 12 women) with 28 adjacent tandem aneurysms were treated during the study timeframe. Aneurysms were located along the clinoidal, ophthalmic, and communicating segments of the internal carotid artery in 12 patients and at the basilar apex in one patient. Average size was 8.4 mm. Six patients (12 aneurysms) were treated by flow diversion via the Pipeline embolization device (PED) and seven (16 aneurysms) by stent-assisted coiling, with coils successfully placed in 11 aneurysms. Clinical follow-up was available for an average of 26.1 months; postprocedural angiography was performed for 12 patients. Complete occlusion was achieved in nine of ten (90 %) PED-treated aneurysms and eight of 11 (72.7 %) treated by stent-assisted coiling (p = 0.44). Two patients treated by stent-assisted coiling required re-coiling for aneurysm recanalization. Overall, modified Rankin scale scores were 0-1 for 12 patients and 3 for one patient.
CONCLUSIONS: Adjacent tandem intracranial aneurysms can be safely and effectively treated by either stent-assisted coiling or flow diversion. We prefer PED flow diversion due to better parent vessel reconstruction and lower recanalization risk.

Entities:  

Mesh:

Year:  2015        PMID: 25572632     DOI: 10.1007/s00701-014-2318-z

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  6 in total

1.  One and done? The effect of number of Pipeline embolization devices on aneurysm treatment outcomes.

Authors:  Muhammad Waqas; Kunal Vakharia; Andrew D Gong; Hamid H Rai; Audrey Wack; Najya Fayyaz; Kenneth V Snyder; Jason M Davies; Adnan H Siddiqui; Elad I Levy
Journal:  Interv Neuroradiol       Date:  2019-11-25       Impact factor: 1.610

Review 2.  Endovascular treatment of cerebral aneurysms using flow-diverter devices: A systematic review.

Authors:  Francesco Briganti; Giuseppe Leone; Mariano Marseglia; Giuseppe Mariniello; Ferdinando Caranci; Arturo Brunetti; Francesco Maiuri
Journal:  Neuroradiol J       Date:  2015-08-27

3.  Stepwise stent deployment technique for tandem intracranial aneurysms: a review of 21 cases.

Authors:  Yi-Bin Fang; Zhao-Long Zhang; Peng-Fei Yang; Wan-Ling Wen; Bo Hong; Yi Xu; Wen-Yuan Zhao; Qing-Hai Huang; Jian-Min Liu
Journal:  Eur Radiol       Date:  2015-05-26       Impact factor: 5.315

4.  Treatment of Tandem Internal Carotid Artery Aneurysms Using a Single Pipeline Embolization Device: Evaluation of Safety and Efficacy.

Authors:  N Adeeb; J M Moore; C J Griessenauer; P M Foreman; H Shallwani; A A Dmytriw; H Shakir; A H Siddiqui; E I Levy; J M Davies; M R Harrigan; A J Thomas; C S Ogilvy
Journal:  AJNR Am J Neuroradiol       Date:  2017-05-18       Impact factor: 3.825

Review 5.  [Management of paraophthalmic aneurysms : Review of endovascular treatment strategies].

Authors:  P Bhogal; M Aguilar Pérez; G Sauder; H Bäzner; O Ganslandt; H Henkes
Journal:  Ophthalmologe       Date:  2018-02       Impact factor: 1.059

6.  Treatment of Unruptured, Tandem Aneurysms of the ICA with a Single Flow Diverter.

Authors:  P Bhogal; J Chudyk; C Bleise; I Lylyk; N Perez; H Henkes; P Lylyk
Journal:  Clin Neuroradiol       Date:  2018-08-30       Impact factor: 3.649

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.